179 related articles for article (PubMed ID: 9438536)
1. Characteristics of serum hyaluronate concentrations in patients with alcoholic liver disease.
Tsutsumi M; Urashima S; Takase S; Ueshima Y; Tsuchishima M; Shimanaka K; Kawahara H
Alcohol Clin Exp Res; 1997 Dec; 21(9):1716-21. PubMed ID: 9438536
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical study of hyaluronate receptor (CD44) in alcoholic liver disease.
Urashima S; Tsutsumi M; Ozaki K; Tsuchishima M; Shimanaka K; Ueshima Y; Takase S
Alcohol Clin Exp Res; 2000 Apr; 24(4 Suppl):34S-38S. PubMed ID: 10803777
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of hepatitis GB virus C infection in alcoholic liver disease.
Tsutsumi M; Sawada M; Takase S; Chen WB; Ueshima Y; Tsuchishima M; Shimanaka K; Itoh T; Kawahara H
Alcohol Clin Exp Res; 1997 Dec; 21(9):1722-5. PubMed ID: 9438537
[TBL] [Abstract][Full Text] [Related]
4. Serum hyaluronate predicts response to interferon-alpha therapy in patients with chronic hepatitis C.
Ueno T; Inuzuka S; Sata M; Koh H; Tamaki S; Kin M; Sugawara H; Sakata R; Torimura T; Tanikawa K
Hepatogastroenterology; 1995; 42(5):522-7. PubMed ID: 8751209
[TBL] [Abstract][Full Text] [Related]
5. Serum hyaluronate reflects hepatic fibrogenesis in alcoholic liver disease and is useful as a marker of fibrosis.
Parés A; Deulofeu R; Giménez A; Caballería L; Bruguera M; Caballería J; Ballesta AM; Rodés J
Hepatology; 1996 Dec; 24(6):1399-403. PubMed ID: 8938169
[TBL] [Abstract][Full Text] [Related]
6. The levels of serum fibrosis marks and morphometric quantitative measurement of hepatic fibrosis.
Xie SB; Yao JL; Zheng SS; Yao CL; Zheng RQ
Hepatobiliary Pancreat Dis Int; 2002 May; 1(2):202-6. PubMed ID: 14607739
[TBL] [Abstract][Full Text] [Related]
7. [Diagnostic value of five serum markers for liver fibrosis].
Luo R; Yang S; Xie J; Zhao Z; He Y; Yao J
Zhonghua Gan Zang Bing Za Zhi; 2001 Jun; 9(3):148-50. PubMed ID: 11412388
[TBL] [Abstract][Full Text] [Related]
8. Serum levels of fibrosis biomarkers measured early after liver transplantation are associated with severe hepatitis C virus recurrence.
Micheloud D; Salcedo M; Bañares R; Rincón D; Lorente R; Muñoz-Fernández MA; Resino S
Transpl Infect Dis; 2009 Apr; 11(2):183-8. PubMed ID: 19254326
[TBL] [Abstract][Full Text] [Related]
9. [A quantitative study of the relationship between levels of liver fibrosis markers in sera and fibrosis stages of liver tissues of patients with chronic hepatic diseases].
Ding XJ; Li SB; Li SZ; Liu HS; Liu B; Xu FM; Gu RW
Zhonghua Gan Zang Bing Za Zhi; 2005 Dec; 13(12):911-4. PubMed ID: 16381637
[TBL] [Abstract][Full Text] [Related]
10. Assessment of liver fibrosis development in chronic hepatitis B patients by serum hyaluronic acid and laminin levels.
Parsian H; Rahimipour A; Nouri M; Somi MH; Qujeq D
Acta Clin Croat; 2010 Sep; 49(3):257-65. PubMed ID: 21462814
[TBL] [Abstract][Full Text] [Related]
11. Value of fibrosis markers for staging liver fibrosis in patients with precirrhotic alcoholic liver disease.
Lieber CS; Weiss DG; Paronetto F;
Alcohol Clin Exp Res; 2008 Jun; 32(6):1031-9. PubMed ID: 18422837
[TBL] [Abstract][Full Text] [Related]
12. The relationship between staging of hepatic fibrosis and the levels of serum biochemistry.
Xu GG; Luo CY; Wu SM; Wang CL
Hepatobiliary Pancreat Dis Int; 2002 May; 1(2):246-8. PubMed ID: 14612277
[TBL] [Abstract][Full Text] [Related]
13. [The diagnostic value of serum hyaluronic acid, 7S domain of type IV collagen and AST/ALT ratio as markers of hepatic fibrosis in chronic hepatitis B and cirrhosis patients].
Park JH; Park CK; Kim ES; Park SY; Jo CM; Tak WY; Kweon YO; Kim SK; Choi YW
Taehan Kan Hakhoe Chi; 2003 Jun; 9(2):79-88. PubMed ID: 12824747
[TBL] [Abstract][Full Text] [Related]
14. Histochemical study of hyaluronate in alcoholic liver disease.
Urashima S; Tsutsumi M; Shimanaka K; Ueshima Y; Tsuchishima M; Itoh T; Kawahara H; Takase S
Alcohol Clin Exp Res; 1999 Apr; 23(4 Suppl):56S-60S. PubMed ID: 10235280
[TBL] [Abstract][Full Text] [Related]
15. Serum hyaluronic acid as a marker of hepatic fibrosis.
Khan JA; Khan FA; Dilawar M; Ijaz A; Khan NA; Mehmood T
J Coll Physicians Surg Pak; 2007 Jun; 17(6):323-6. PubMed ID: 17623578
[TBL] [Abstract][Full Text] [Related]
16. [Screening and evaluation of non-invasive diagnosis markers for compensated liver cirrhosis in patients with chronic hepatitis B].
Chen YP; Feng XR; Dai L; Ding HB; Zhang L
Zhonghua Gan Zang Bing Za Zhi; 2003 Apr; 11(4):225-7. PubMed ID: 12716522
[TBL] [Abstract][Full Text] [Related]
17. [Comparison of six potential serum markers of hepatic fibrosis in alcoholic disease of the liver].
Grimbert S; Trinchet JC; Hartmann DJ; Munz C; Garnier M; Mal F; Callard P; Beaugrand M
Gastroenterol Clin Biol; 1993; 17(8-9):570-7. PubMed ID: 8253314
[TBL] [Abstract][Full Text] [Related]
18. Serum hyaluronic acid, procollagen type III and IV in histological diagnosis of liver fibrosis.
Xie SB; Yao JL; Zheng RQ; Peng XM; Gao ZL
Hepatobiliary Pancreat Dis Int; 2003 Feb; 2(1):69-72. PubMed ID: 14607650
[TBL] [Abstract][Full Text] [Related]
19. [Diagnostic significance of type IV collagen and hyaluronic acid in the serum of patients with chronic hepatitis C for staging hepatic fibrosis].
Iushchuk ND; Znoĭko OO; Safiullina NKh; Dudina KR; Kelli EI; Klimova EA; Kashirin VI; Braginskiĭ DM; Kushlinskiĭ NE; Liubimova NV; Vasilev AIu; Penkina TV; Danilin AG
Ter Arkh; 2005; 77(4):50-5. PubMed ID: 15938533
[TBL] [Abstract][Full Text] [Related]
20. Changes in type IV collagen content in livers of patients with alcoholic liver disease.
Tsutsumi M; Urashima S; Matsuda Y; Takase S; Takada A
Hepatology; 1993 May; 17(5):820-7. PubMed ID: 8491450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
